Hualan Biological Engineering
002007.SZ
#3467
Rank
C$5.46 B
Marketcap
C$2.99
Share price
0.13%
Change (1 day)
-11.68%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2025 (TTM): C$0.27 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are C$0.63 Billion. In 2024 the company made an earning of C$0.25 Billion a decrease over its 2023 earnings that were of C$0.40 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.27 B7.19%
2024 C$0.25 B-36.03%
2023 C$0.40 B39.14%
2022 C$0.28 B-19.27%
2021 C$0.35 B-17.84%
2020 C$0.43 B37.54%
2019 C$0.31 B11.56%
2018 C$0.28 B50.74%
2017 C$0.18 B1.03%
2016 C$0.18 B23.54%
2015 C$0.15 B8.4%
2014 C$0.13 B10.91%
2013 C$0.12 B54.55%
2012 C$81.01 M-17.1%
2011 C$97.71 M-41.28%
2010 C$0.16 B6.13%
2009 C$0.15 B261.35%
2008 C$43.39 M85.72%
2007 C$23.36 M49.33%
2006 C$15.64 M56.91%
2005 C$9.97 M34.29%
2004 C$7.42 M